In addition, the impact of endoglin on the diagnostics, etiology, or prognosis in various diseases such as hereditary hemorrhagic telangiectasia, preeclampsia, cancer, hyperglycemia, atherosclerosis, hypercholesterolemia, kidney and liver fibrosis, septic syndrome, nonalcoholic steatohepatitis (NASH), and systemic sclerosis has been reported [37, 38, 62, 74–78]. Here, ENG is linked to metabolic dysfunction-associated steatohepatitis.